Clinical Trials Directory

Trials / Completed

CompletedNCT00642876

PRESTIGE® Cervical Disc Study

Investigation of the PRESTIGE® Cervical Disc Device at a Single Level for Symptomatic Cervical Disc Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
541 (actual)
Sponsor
Medtronic Spinal and Biologics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a PMA application for the ACD.

Conditions

Interventions

TypeNameDescription
DEVICEAllograft Fusion and ATLANTIS™ Cervical Plate SystemThe patients that received the control treatment underwent a single level anterior cervical fusion procedure involving allograft bone and the ATLANTIS™ Cervical Plate System.
DEVICEPRESTIGE® Cervical DiscThe PRESTIGE® Cervical Disc is a stainless steel device that was inserted into the intervertebral disc space. The device is composed of two metal plates that interface via a ball and socket mechanism permitting segmental spinal motion.

Timeline

Start date
2002-10-01
Primary completion
2006-07-01
Completion
2013-05-01
First posted
2008-03-25
Last updated
2023-05-10

Locations

31 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00642876. Inclusion in this directory is not an endorsement.